SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 97 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2015. The put-call ratio across all filers is 1.33 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $85,000 | -74.7% | 327,173 | -76.6% | 0.00% | -71.4% |
Q1 2016 | $336,000 | +6620.0% | 1,398,330 | +9284.8% | 0.01% | – |
Q4 2015 | $5,000 | -99.3% | 14,900 | -96.6% | 0.00% | -100.0% |
Q3 2015 | $766,000 | +53.8% | 440,377 | +97.1% | 0.02% | +77.8% |
Q2 2015 | $498,000 | +196.4% | 223,474 | +158.4% | 0.01% | +200.0% |
Q1 2015 | $168,000 | -87.8% | 86,470 | -83.4% | 0.00% | -87.5% |
Q4 2014 | $1,381,000 | +327.6% | 521,078 | +386.1% | 0.02% | +380.0% |
Q3 2014 | $323,000 | -25.7% | 107,200 | +0.8% | 0.01% | -28.6% |
Q2 2014 | $435,000 | – | 106,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 30,197,945 | $80,025,000 | 92.06% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 457,458 | $1,212,000 | 0.22% |
Verity Asset Management, Inc. | 82,383 | $218,000 | 0.21% |
STONERIDGE INVESTMENT PARTNERS LLC | 332,238 | $880,000 | 0.12% |
Cutler Capital Management, LLC | 62,500 | $165,000 | 0.07% |
Capital Impact Advisors, LLC | 37,788 | $100,000 | 0.05% |
SECOR Capital Advisors, LP | 35,087 | $93,000 | 0.04% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 50,814 | $134,000 | 0.04% |
BOLTON LP | 37,700 | $100,000 | 0.03% |
BOLTON LP | 37,700 | $100,000 | 0.03% |